Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -11.91%.However, over the last six months, we can see a stronger performance of -36.70%. Over the last 30 days, the price of AUTL has fallen by 53.33%. And in the last five days, it has surged by 31.85%.
Autolus Therapeutics plc ADR’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $5.00 on 10/18/24, and the lowest price during that time was $1.11, recorded on 04/11/25.
52-week price history of AUTL Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Autolus Therapeutics plc ADR’s current trading price is -58.60% away from its 52-week high, while its distance from the 52-week low is 87.33%. The stock’s price range for this period has been between $1.11 and $5.00. The Healthcare sector company’s shares saw a trading volume of about 5.9 million for the day, which was higher than the average daily volume of 1.97 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly rise of 13.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 550.91M and boasts a workforce of 647 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7400, with a change in price of -0.4500. Similarly, Autolus Therapeutics plc ADR recorded 1,731,269 in trading volume during the last 100 days, posting a change of -17.86%.
AUTL’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AUTL stands at 0.84. Similarly, the long-term debt-to-equity ratio is also 0.83.
AUTL Stock Stochastic Average
As of today, the raw stochastic average of Autolus Therapeutics plc ADR over the last 50 days is at 91.04%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 90.64%. Further, the company’s Stochastic %K and %D values for the last 20 days were 93.13% and 93.95%, respectively.
